Alltrna

Our CEO Michelle Werner chats with Tides Global about her journey leading up to being CEO at Alltrna and how her personal experiences influenced her career to advance novel therapeutics. Read more at @Informa: https://lnkd.in/g-2cBwry #rarediseases #geneticmedicines #tRNA

Had a great discussion today with Congressional leaders and Paul Melmeyer of the Muscular Dystrophy Association and Maynard Friesz of Cure SMA about the importance of the rare pediatric disease priority review voucher (PRV) program. Thank you to National Organization for Rare Disorders for organizing the Senate briefing and to Karin Hoelzer for moderating. #PRV #rarediseases #raredisease #drugdevelopment #innovation #patientsdeservebetter

Our CEO Michelle Werner will be speaking tomorrow to Congressional leaders about the vital importance of the rare pediatric disease priority review voucher (PRV) program. The reauthorization of the #PRV program before the September 30th deadline would continue the crucial incentives for developing new treatments for pediatric #rarediseases. More information about the event, the draft agenda, and National Organization for Rare Disorders’ recent white paper analyzing the program’s impact can be found here: https://lnkd.in/d_v2bnrb

Please join us in welcoming Chris Schade, Lynne Parshall, Robert Plenge, and Nancy Simonian, who join Lovisa Afzelius and Michelle Werner on Alltrna’s Board of Directors. Their expertise will help guide us as we advance our first #tRNA medicines to the clinic for #StopCodonDisease and build a new future for patients. Read the release here: https://lnkd.in/g8XK8wJd #tRNAmedicine #rarediseases #FlagshipFounded

What will it take to advance the first tRNA medicines into the clinic? 🎙️ Tune in to this podcast with RNA Leaders to hear our CEO Michelle Werner share her thoughts about the next steps to support the development of this unique therapeutic modality, which has the potential to scale and accelerate genetic medicines for rare diseases. Michelle also previews what she plans to present at this year's conference in September. Listen here: https://lnkd.in/gPqgNu3R #RNALeaders #RNALeaders24 #tRNA #RNA #tRNAmedicines #tRNAbiology #rarediseases #geneticmedicines #programmablemedicines #machinelearning #AI #StopCodonDisease

Companies pioneering original science are essential to scaling and accelerating meaningful new medicines for patients – especially those with #rarediseases. We are proud to be one with the first #tRNA platform company to decipher tRNA biology and pioneer new #geneticmedicines to treat thousands of diseases. Congrats to Flagship Pioneering on this raise to fuel breakthrough innovations that transform health and sustainability. We are proud to be #FlagshipFounded and part of an ecosystem of companies – present and future – taking bold scientific leaps to deliver a better future for all.

As part of #PrideMonth2024, we hosted a book club and read “The Autobiography of a Transgender Scientist” by Dr. Ben Barres. Dr. Barres’s legacy is two-fold: making breakthrough discoveries for neuroscience by elucidating the role of glial cells and his groundbreaking advocacy for gender equality in science. This book resonates with us deeply. At Alltrna, we believe in the power of bringing your whole-self to work. Because only when we can be authentic to ourselves can we unleash the full power of who we are and what we can do. We also had a celebratory brunch and raised money for BAGLY, Inc., a social support organization committed to creating, sustaining, and advocating for programs, policies, and services for the GLBT youth community in Boston. Thanks to the team for a great #PrideMonth! #WeAreAlltrna

Inspiring words from Alltrna CEO Michelle Werner, who shared her personal and professional drive for accelerating and scaling the development of new genetic medicines for #rarediseases with Patrick Short on The Genetics Podcast. Listen as she discusses how she’s applying her experience in oncology drug development leveraging basket clinical trials to advance tRNA therapeutics, which have the potential to be developed as a universal medicine to treat hundreds of genetic diseases. Hear more here: 🎧 https://pod.fo/e/249755 📺 https://lnkd.in/eYgkwVPz Sano Genetics #tRNA #RNA #tRNAmedicines #tRNAbiology #raredisease  #geneticmedicines #programmablemedicines #machinelearning #AI

🧬 RNA Therapeutics, from Concept to Clinic 🧬 Our VP, Discovery Platform, Caroline Köhrer, will be speaking at #RNATx2024 next week and sharing how Alltrna is developing #tRNA medicines for #StopCodonDisease. ➡️ Virtual registration still open: https://lnkd.in/g9U28z8 #RNA #tRNAmedicines #tRNAbiology #rarediseases #raredisease #geneticmedicines

Disease-by-disease, gene-by-gene drug development remains prohibitively expensive for the 6,000+ ultra-rare and #rarediseases that have been genetically defined. Alltrna’s CEO Michelle Werner explains how #tRNA could radically transform this #drugdevelopment paradigm to scale and accelerate new #geneticmedicines. Read more in this Technology Networks feature Q&A: https://lnkd.in/deVHF6QR #StopCodonDisease #RareDisease #tRNA #RNA #tRNAmedicines #tRNAbiology #programmablemedicines